ALT vs NI · rev $5.0K vs P/E 23, rev $3.61B
Altimmune Inc (ALT) versus NiSource Inc (NI) — a side-by-side from cached financials, not a winner call.
Altimmune Inc (ALT) is a biotechnology company listed on US.
NiSource Inc (NI) is a utilities - regulated gas company listed on NYSE.
Latest reported ALT revenue for 2025-09-30 was $5.0K. Net income was -$60.7M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. ALT currently screens at market cap $527.0M.
Latest reported NI revenue for 2026-06-30 was $3.61B. Net income was $552.6M. Revenue was up 55.5% from 2026-03-31 to 2026-06-30. NI currently screens at market cap $22.42B and trailing P/E 23.3.
ALT currently screens at market cap $527.0M. NI currently screens at market cap $22.42B and trailing P/E 23.3.
Not investment advice. Open the ALT and NI stock pages for the full models.
Not investment advice.